Recently released draft guidance for implementing Medicare price caps would allow voluntary provider use of 340B codes on claims, while [...] …
Year: 2024
Drug spending increased by 13.6% in 2023 to $722.5 billion, according to recent research. It found divergent trends for clinic [...] …
North Carolina hospitals that participate in the 340B program routinely overcharged cancer patients, taxpayers and state employees for oncology drugs, [...] …
Groups representing hospitals that rely on the 340B program recently urged congressional advisers against recommending reduced Medicare reimbursement to 340B [...] …
SPONSORED CONTENT
Attention 340B Covered Entities: For most covered entities, the 340B program is essential to their organization’s bottom line – so protecting it becomes necessary. 340B program risks are numerous and often not fully recognized. Duplicate discounts, diversion, and poor documentation are common
…
Pharmaceutical giant Pfizer announced it exempted Arkansas hospitals from its 340B contract pharmacy restrictions beginning this week. Effective May 6, [...] …
Influential Delaware Democratic lawmakers last week introduced legislation to bar drugmaker 340B contract pharmacy restrictions and prohibit certain 340B-specific pharmacy [...] …
While newly enrolled 340B hospital entrants served higher numbers of Medicaid and rural patients than non-340B hospitals, government-owned 340B hospitals [...] …
Federal auditors closed audits with corrective action plans (CAPs) for eight more 340B providers, which brought the fiscal year 2023 [...] …
Drugmaker Novo Nordisk this week announced that its contract pharmacy restrictions will soon apply to all grantee covered entities—not just [...] …